Clinical trial · Interventional
Trial of Open Versus Laparoscopic Radical Cystectomy at a Laparoscopic Naive Center
Randomised Controlled Trial of Open Versus Laparoscopic Radical Cystectomy at a Laparoscopic Naive Center
NCT04838873CI-TRIAL-00051193completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is a prospective randomised controlled study of urinary bladder cancer patients presented to urology unit at National Cancer Institute; Cairo University.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
| Laparoscopy | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Laparoscopic-assisted radical cystectomy | Procedure | — | UNRESOLVED |
| Open radical cystectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Open Radical Cystectomy
- description
- Standard open radical cystectomy.
- interventionNames
- Procedure: Open radical cystectomy
- type
- EXPERIMENTAL
- label
- Laparoscopic-assisted radical cystectomy.
- description
- Laparoscopic-assisted radical cystectomy.
- interventionNames
- Procedure: Laparoscopic-assisted radical cystectomy
Primary outcomes (13)
- measure
- Operative time
- timeFrame
- During surgery
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 30 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with transitional cell carcinoma, squamous cell carcinoma and urinary bladder adenocarcinoma. * Patients fit for surgery (ECOG Performance Status 0,1). Exclusion Criteria: * Patients with medical comorbidities that preclude surgical management or minimally invasive techniques. * Patients with advanced hydronephrosis or renal failure. * Patients refusing surgery. * Patients with urinary bladder cancer invading bladder neck or prostatic urethra. * Patients with metastatic urinary bladder cancer. * Patients who received prior pelvic radiotherapy. * Patients refusing randomization and/or participation in the trial.
References
Publications (0)
Data not yet available
No reference posted for this study.